NCT02040636View on ClinicalTrials.gov

Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis

PHASE2CompletedINTERVENTIONAL
Enrollment

277

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

May 31, 2000

Study Completion Date

May 31, 2000

Conditions
PertussisTetanusDiphtheriaPoliomyelitisHepatitis B
Interventions
BIOLOGICAL

Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis Vaccine and IPV

0.5 mL, Intramuscular

BIOLOGICAL

Hepatitis B vaccine

0.5 ml, Intramuscular

Trial Locations (1)

R3E 3P4

Winnipeg

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT02040636 - Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis | Biotech Hunter | Biotech Hunter